Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDx Breast test.
Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDxBreast test.
DtectDxBreast is essentially a blood test for the detection of breast cancer and is meant to be used in conjunction with mammography. With this test, Henderson says, information is available for a physician to make a decision regarding further imaging or biopsying.
DtectDxBreast is especially beneficial for women under 50 years, who tend to be underserved by mammography. The test is also beneficial, Henderson says, as it should not be affected by dense breast tissue or previous biopsy. If imaging is difficult or confounding in a patient, an empirical value from the dtectDxBreast test is still possible.
Clinical Pearls
Sequencing Sacituzumab and Other Drugs in HR+, HER2- Breast Cancer
May 16th 2024During a Case-Based Roundtable® event, Stephanie L. Graff, MD, discussed multiple later-line treatment options in hormone receptor–positive breast cancer with participants in the first article of a 2-part series.
Read More
Darolutamide Becomes Routine Doublet and Triplet Option in Hormone-Sensitive Prostate Cancer
May 6th 2024Darolutamide has been adopted routinely in clinical practice as a component of both doublet and triplet regimens for the treatment of patients with metastatic hormone-sensitive prostate cancer.
Read More